scispace - formally typeset
K

Kevin Sweet

Researcher at Ohio State University

Publications -  72
Citations -  3517

Kevin Sweet is an academic researcher from Ohio State University. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 26, co-authored 64 publications receiving 3163 citations. Previous affiliations of Kevin Sweet include University of Texas Medical Branch.

Papers
More filters
Journal ArticleDOI

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Nasim Mavaddat, +132 more
TL;DR: Pathologic characteristics of BRCA1 and BRCa2 tumors may be useful for improving risk-prediction algorithms and informing clinical strategies for screening and prophylaxis.
Journal ArticleDOI

Highly penetrant hereditary cancer syndromes.

TL;DR: In this review, 10 of the more highly penetrant cancer syndromes are considered, with emphasis on those predisposing to breast, colon, and/or endocrine neoplasia, as well as their underlying genetic defects.
Journal ArticleDOI

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Kelly A. Metcalfe, +46 more
TL;DR: Nearly one‐half of the women at risk for breast cancer had taken no preventive option, relying solely on screening, and there were large differences in the uptake of the different preventive options by country of residence.
Journal ArticleDOI

22q13 deletion syndrome

TL;DR: The features most frequently associated with this deletion are global developmental delay, generalized hypotonia, absent or severely delayed speech, and normal to advanced growth.
Journal ArticleDOI

Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis

TL;DR: Systematic molecular classification of 49 patients with unexplained hamartomatous or hyperplastic polyposis uncovered a potential novel susceptibility gene, ENG, for juvenilepolyposis, which should be considered routinely as organ-specific surveillance rests on defining syndromic diagnosis.